Ameriprise Financial Inc United Therapeutics Corp Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 66,869 shares of UTHR stock, worth $25.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
66,869
Previous 73,297 8.77%
Holding current value
$25.8 Million
Previous $23.3 Million 2.63%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$311.04 - $363.55 $2 Million - $2.34 Million
-6,428 Reduced 8.77%
66,869 $24 Million
Q2 2024

Aug 14, 2024
BUY
$228.26 - $319.04 $525,226 - $734,111
2,301 Added 3.24%
73,297 $23.3 Million
Q1 2024

May 15, 2024
SELL
$210.76 - $249.51 $429,318 - $508,251
-2,037 Reduced 2.79%
70,996 $16.3 Million
Q4 2023

Feb 14, 2024
SELL
$214.88 - $256.94 $1.38 Million - $1.65 Million
-6,406 Reduced 8.06%
73,033 $16.1 Million
Q3 2023

Nov 14, 2023
SELL
$211.82 - $248.24 $207,159 - $242,778
-978 Reduced 1.22%
79,439 $17.9 Million
Q2 2023

Aug 14, 2023
SELL
$205.19 - $232.99 $1.32 Million - $1.5 Million
-6,453 Reduced 7.43%
80,417 $17.8 Million
Q1 2023

May 15, 2023
BUY
$212.99 - $276.17 $1.57 Million - $2.03 Million
7,359 Added 9.26%
86,870 $19.5 Million
Q4 2022

Feb 14, 2023
SELL
$205.95 - $280.43 $573,776 - $781,277
-2,786 Reduced 3.39%
79,511 $22.1 Million
Q3 2022

Nov 14, 2022
BUY
$203.3 - $244.17 $313,082 - $376,021
1,540 Added 1.91%
82,297 $17.2 Million
Q2 2022

Aug 15, 2022
SELL
$174.81 - $241.14 $307,141 - $423,682
-1,757 Reduced 2.13%
80,757 $19 Million
Q1 2022

May 16, 2022
SELL
$166.16 - $213.96 $171,809 - $221,234
-1,034 Reduced 1.24%
82,514 $14.8 Million
Q4 2021

Feb 14, 2022
BUY
$184.32 - $216.08 $396,472 - $464,788
2,151 Added 2.64%
83,548 $18.1 Million
Q3 2021

Nov 15, 2021
SELL
$179.86 - $214.88 $434,901 - $519,579
-2,418 Reduced 2.88%
81,397 $15 Million
Q2 2021

Aug 16, 2021
SELL
$170.47 - $211.93 $12.3 Million - $15.3 Million
-72,266 Reduced 46.3%
83,815 $15 Million
Q1 2021

May 17, 2021
SELL
$153.94 - $174.85 $3.67 Million - $4.17 Million
-23,828 Reduced 13.24%
156,081 $26.1 Million
Q4 2020

Feb 12, 2021
SELL
$101.87 - $151.79 $2.19 Million - $3.27 Million
-21,544 Reduced 10.69%
179,909 $27.3 Million
Q3 2020

Nov 16, 2020
BUY
$99.9 - $121.13 $632,766 - $767,237
6,334 Added 3.25%
201,453 $20.3 Million
Q2 2020

Aug 14, 2020
BUY
$92.74 - $125.82 $1.43 Million - $1.94 Million
15,424 Added 8.58%
195,119 $23.6 Million
Q1 2020

May 15, 2020
BUY
$79.39 - $115.35 $4.46 Million - $6.48 Million
56,200 Added 45.51%
179,695 $17 Million
Q4 2019

Feb 14, 2020
SELL
$78.31 - $95.34 $573,699 - $698,460
-7,326 Reduced 5.6%
123,495 $10.9 Million
Q3 2019

Nov 14, 2019
BUY
$74.85 - $85.99 $1.17 Million - $1.35 Million
15,668 Added 13.61%
130,821 $10.4 Million
Q2 2019

Aug 14, 2019
SELL
$76.06 - $120.81 $530,518 - $842,649
-6,975 Reduced 5.71%
115,153 $8.99 Million
Q1 2019

May 15, 2019
SELL
$107.15 - $126.84 $349,416 - $413,625
-3,261 Reduced 2.6%
122,128 $14.3 Million
Q4 2018

Feb 14, 2019
SELL
$101.4 - $128.73 $879,442 - $1.12 Million
-8,673 Reduced 6.47%
125,389 $13.7 Million
Q3 2018

Nov 14, 2018
BUY
$113.81 - $129.46 $179,933 - $204,676
1,581 Added 1.19%
134,062 $17.1 Million
Q2 2018

Aug 14, 2018
BUY
$101.14 - $118.31 $334,065 - $390,777
3,303 Added 2.56%
132,481 $15 Million
Q1 2018

May 15, 2018
SELL
$107.21 - $151.94 $4.31 Million - $6.11 Million
-40,195 Reduced 23.73%
129,178 $14.5 Million
Q4 2017

Feb 12, 2018
BUY
$118.58 - $151.28 $268,346 - $342,346
2,263 Added 1.35%
169,373 $25.1 Million
Q3 2017

Nov 07, 2017
BUY
$114.6 - $136.81 $19.2 Million - $22.9 Million
167,110
167,110 $19.6 Million

Others Institutions Holding UTHR

# of Institutions
657
Shares Held
42.8M
Call Options Held
153K
Put Options Held
278K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email